News

   Daily Updated Pharma-News regarding R&D, FDA, F&D, Pharmaceuticals industries, Hospital Pharmacy and Pharmaceutical Development...

• Bayer begins phase-I study with Idiotype vaccination, a personalized vaccine from tobacco plants to treat non-Hodgkin's lymphoma
• Bombay HC restrains Cipla from using Valcept trade mark for its anti viral drug valganciclovir
• FDA Approves New Lidocaine-Containing Dermal Filler Formulation
• Olanzapine Label for Adolescent Indication Changed

• Researchers discover new genes that account for new forms of osteogenesis imperfecta
• Living Cell Technologies gets European patent for neurological disease product NTCELL
• Intensive Insulin Therapy May Not Improve Survival in Septic Shock
• Study shows IMUC's lead investigational cancer vaccine ICT-107 targets cancer stem cells

• Mother Teresa Institute in Pondicherry to introduce diploma courses in pharmacy & nursing in Ayurveda
• Karnataka drugs control department issues 291 show cause notices to sales units
• Illumina launches HySeq 2000
• FDA Approves Dalfampridine to Improve Walking in Multiple Sclerosis
• Early Beta-Blockade for ACS Does Not Alter Short-Term Mortality
• Amarin Corporation Announces First Patients Enrolled In Two Phase 3 Clinical Trials Assessing AMR101 for the Treatment of Cardiovascular Disease

• India, other countries raise 'false pandemic' issue at WHO board meeting
• DBT collaborates with Germany for research projects in biotechnology
• Data from Ecole polytechnique federale de Lausanne advance knowledge in gene therapy
• 23 new drug inspectors appointed in Tamil Nadu
• ICMR to support project to develop vaccine to prevent bacterial infection in ICU patients

• Dr Reddy's suffer net loss of Rs 522 cr in Q3
• FDA clears Lupin's Mandideep drug plant
• Wockhardt Foundation joins hands with Sanjay Nirupam Helpline to serve the underprivileged
• Antibodies Plus Antibiotics Decreases Clostridium difficile Infection Recurrence
• US FDA warns consumers about counterfeit Alli

• Mahrashtra FDA finds 24 drugs sub-standard on testing in December
• NATIONAL CONFERENCE CELLULAR AND MOLECULAR MEDICINE, Feb 4-6
• Ranbaxy enters vax space, acquires Biovel
• Bangalore Bio from June 2-4

• Path Malaria Vaccine Initiative inks pact with JHSPH & Sabin Vaccine Institute to eradicate malaria
• Hormone Therapy Ups All-Cause Mortality in Older Men With Localized Prostate Cancer
• Eisai applies for additional indication of anti-arrhythmic agent Tambocor tabs in Japan
• US FDA biopharmaceutical approval registers sharp rise in 2009
• InSightec gets approval for MRgFUS system for treatment of uterine fibroids
• Indian researchers develops nano version of a cancer drug

• Reata Pharma licenses chronic kidney disease drug bardoxolone methyl to Kyowa Hakko Kirin
• US FDA approves humanized anti-human IL-6 receptor monoclonal antibody Actemra to treat RA
• Opportunities, critical success factors for Indian biosimilar players
• Calcium, Avoiding Smoking May Limit Birth-Control Bone Loss

• DST to reformulate policy on science & technology incorporating new
• Sopherion gets US FDA fast track status for Myocet in metastatic breast cancer
• Thoracoabdominal Calcifications May Predict Cardiovascular Mortality
• Hip Fracture Risk Elevated With Pernicious Anemia: Study
• Health ministry amends rule for homoeopathic hair oils under D&C Act

------------------------------------------